Hypertension in Children and Adolescents – Diagnostic Challenges and Management
symptomatic hypertension. The choice of the antihypertensive often depends on the cause of the hypertension, but the most efficacious medications should be considered. Over time, developing countries will experience increasing rates of hypertension and approach those seen in
1. Whitworth JA, 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension, J Hypertens, 2003;21(11):1983–92.
2. Feber J, Ahmed M, Hypertension in children: new trends and challenges, Clin Sci (Lond), 2010;119(4):151–61.
3. Nguyen QC, Tabor JW, Entzel PP, et al., Discordance in National Estimates of Hypertension Among Young Adults, Epidemiology, 2011;22(4):532–41.
4. Muntner P, He J, Cutler JA, et al., Trends in blood pressure among children and adolescents, JAMA, 2004;291(17):2107–13.
5. Brady TM, Fivush B, Parekh RS, Flynn JT, Racial differences among children with primary hypertension, Pediatrics, 2010;126(5):931–7.
6. Jalal DI, Smits G, Johnson RJ, Chonchol M, Increased fructose associates with elevated blood pressure, J Am Soc Nephrol, 2010;21(9):1543–9.
7. Marriott BP, Cole N, Lee E, National estimates of dietary fructose intake increased from 1977 to 2004 in the United States, J Nutr, 2009;139(6):1228S–1235S.
8. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents, Pediatrics, 2004;114(2 Suppl. 4th Report):555–76.
9. Li J, Motsko SP, Goehring EL Jr, et al., Prevalence of pediatric dyslipidemia: comparison of a population-based claims database to national surveys, Pharmacoepidemiol Drug Saf, 2010;19(10):1031–40.
10. Hansen ML, Gunn PW, Kaelber DC, Underdiagnosis of hypertension in children and adolescents, JAMA, 2007;298(8):874–9.
11. Arnett DK, Glasser SP, McVeigh G, et al., Blood pressure and arterial compliance in young adults: the Minnesota Children’s Blood Pressure Study, Am J Hypertens, 2001;14(3):200–5.
12. Sanchez A, Barth JD, Zhang L, The carotid artery wall thickness in teenagers is related to their diet and the typical risk factors of heart disease among adults, Atherosclerosis, 2000;152(1):265–6.
13. Lurbe E, Cifkova R, Cruickshank JK, et al., Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension, J Hypertens, 2009;27(9):1719–42.
14. McCrindle BW, Assessment and management of hypertension in children and adolescents, Nat Rev Cardiol, 2010;7(3):155–63.
15. Brady TM, Solomon BS, Neu AM, et al., Patient-, provider-, and clinic-level predictors of unrecognized elevated blood pressure in children, Pediatrics, 2010;125(6):e1286–93.
16. Mitchell CK, Theriot JA, Sayat JG, et al., A simplified table improves the recognition of paediatric hypertension, J Paediatr Child Health, 2011;47(1–2):22–6.
17. Ke L, Brock KE, Cant RV, et al., The relationship between obesity and blood pressure differs by ethnicity in Sydney school children, Am J Hypertens, 2009;22(1):52–8.
18. Kaelber, DC, Pickett, FP, Simple table to identify children and adolescents needing further evaluation of blood pressure, Pediatrics, 2009;123(6): e972–e974.
19. Flynn JT, Pediatric hypertension update, Curr Opin Nephrol Hypertens, 2010;19(3):292–7.
20. Falkner B, Lurbe E, Schaefer F, High blood pressure in children: clinical and health policy implications, J Clin Hypertens (Greenwich), 2010;12(4):261–76.
21. Pickering TG, Hall JE, Appel LJ, et al., Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research,
developed countries, leading to an overwhelming burden of paediatric cardiovascular disease worldwide. Addressing detrimental behaviours in childhood may modify the cardiovascular risk carried by children as they age into adults, and may be the best preventative approach. n
Circulation, 2005;111(5):697–716.
22. Williams SK, Ravenell J, Jean-Louis G, et al., Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management, Curr Diab Rep, 2011;11(1):64–9.
23. Sorof J, Daniels S, Obesity hypertension in children: a problem of epidemic proportions, Hypertension, 2002;40(4):441–7.
24. Ziegler MG, Milic M, Sun P, Antihypertensive therapy for patients with obstructive sleep apnea, Curr Opin Nephrol Hypertens, 2011;20(1):50–5.
25. Falkner B, Hypertension in children and adolescents: epidemiology and natural history, Pediatr Nephrol, 2010;25(7):1219–24.
26. Flynn JT, Pediatric hypertension: recent trends and accomplishments, future challenges, Am J Hypertens, 2008;21(6):605–12.
27. Rocchini AP, Key J, Bondie D, et al., The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents, N Engl J Med, 1989;321(9):580–5.
28. Kelley GA, Kelley KS, Tran ZV, The effects of exercise on resting blood pressure in children and adolescents: a meta- analysis of randomized controlled trials, Prev Cardiol, 2003;6(1):8–16.
29. Gidding SS, Barton BA, Dorgan JA, et al., Higher self-reported physical activity is associated with lower systolic blood pressure: the Dietary Intervention Study in Childhood (DISC), Pediatrics, 2006;118(6):2388–93.
30. Mitchell BM, Gutin B, Kapuku G, et al., Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training, Pediatrics, 2002;109(5):E73–3.
31. Fagard RH, Cornelissen VA, Effect of exercise on blood pressure control in hypertensive patients, Eur J Cardiovasc Prev Rehabil, 2007;14(1):12–7.
32. Neter JE, Stam BE, Kok FJ, et al., Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials, Hypertension, 2003;42(5):878–84.
33. Couch SC, Saelens BE, Levin L, et al., The efficacy of a clinic- based behavioral nutrition intervention emphasizing a DASH- type diet for adolescents with elevated blood pressure, J Pediatr, 2008;152(4):494–501.
34. Sacks FM, Appel LJ, Moore TJ, et al., A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study, Clin Cardiol, 1999;22(7 Suppl.):III6–10.
35. US Department of Agriculture, US Department of Health and Human Services, Dietary Guidelines for Americans, 2010. Available at:
www.cnpp.usda.gov/dietaryguidelines.htm (accessed 29 September 2011).
36. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. Available at:
http://oas.samhsa.gov/nsduh/2k6nsduh/2k6results.pdf (accessed 29 September 2011).
37. Flynn JT, Meyers KE, Neto JP, et al., Efficacy and safety of the Angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years, Hypertension, 2008;52(2):222–8.
38. Trachtman H, Hainer JW, Sugg J, et al., Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years, J Clin Hypertens (Greenwich), 2008;10(10):743–50.
39. Webb NJ, Lam C, Loeys T, et al., Randomized, double-blind, controlled study of losartan in children with proteinuria, Clin J Am Soc Nephrol, 2010;5(3):417–24.
40. Schaefer F, van de Walle J, Zurowska A, et al., Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age, J Hypertens, 2010;28(5):1083–90.
41. Gartenmann AC, Fossali E, von Vigier RO, et al., Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood, Kidney Int, 2003;64(4):1450–4.
42. Hazan L, Hernandez Rodriguez OA, Bhorat AE, et al., A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension, Hypertension, 2010;55(6):1323–30.
43. Shahinfar S, Cano F, Soffer BA, et al., A double-blind, dose- response study of losartan in hypertensive children, Am J Hypertens, 2005;18(2 Pt 1):183–90.
44. Flynn JT, Newburger JW, Daniels SR, et al., A randomized, placebo-controlled trial of amlodipine in children with hypertension, J Pediatr, 2004;145(3):353–9.
45. Trachtman H, Frank R, Mahan JD, et al., Clinical trial of extended-release felodipine in pediatric essential hypertension, Pediatr Nephrol, 2003;18(6):548–53.
46. Li JS, Berezny K, Kilaru R, et al., Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?, Hypertension, 2004;44(3):289–93.
47. Soffer B, Zhang Z, Miller K, et al., A double-blind, placebo- controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension, Am J Hypertens, 2003;16(10):795–800.
48. Wells T, Frame V, Soffer B, et al., A double-blind, placebo- controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension, J Clin Pharmacol, 2002;42(8):870–80.
49. Batisky DL, Sorof JM, Sugg J, et al., Toprol-XL Pediatric Hypertension Investigators, Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience, J Pediatr, 2007;150(2):134–9.
50. Sorof JM, Cargo P, Graepel J, et al., Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial, Pediatr Nephrol, 2002;17(5):345–50.
51. Falkner B, Onesti G, Lowenthal DT, Affrime MB, The use of clonidine monotherapy in adolescent hypertension, Chest, 1983;83(2 Suppl.):425–7.
52. Flynn JT, Successes and shortcomings of the Food and Drug Modernization Act, Am J Hypertens, 2003;16(10):889–91.
53. Davis BR, Piller LB, Cutler JA, et al., Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial, Circulation, 2006;113(18):2201–10.
54. Cushman WC, Ford CE, Einhorn PT, et al., Blood pressure control by drug group in the Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), J Clin Hypertens (Greenwich), 2008;10(10):751–60.
55. Wuhl E, Trivelli A, Picca S, et al., Strict blood-pressure control and progression of renal failure in children, N Engl J Med, 2009;361(17):1639–50.
56. Berenson GS, Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study, Am J Cardiol, 2002;90(10C):3L–7L.
57. Julius S, Nesbitt S, Egan B, et al., Trial of preventing hypertension: design and 2-year progress report, Hypertension, 2004;44(2):146–51.
58. Giles TD, The Trial of Preventing Hypertension (TROPHY) as seen through the eyes of the Hypertension Writing Group’s expanded definition of hypertension, J Clin Hypertens (Greenwich), 2006;8(6):441–3.
59. Feber J, Ahmed M, Hypertension in children: new trends and challenges, Clin Sci (Lond), 2010;119(4):151–61.
60. Daniels SR, Greer FR, Lipid screening and cardiovascular health in childhood, Pediatrics, 2008;122(1):198–208.
61. Horsley L, AAP Clinical Report on Lipid Screening in Children, Am Fam Physician, 2009;79(8):703–5.
EUROPEAN NEPHROLOGY
131
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92